A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd.
Jiangsu HengRui Medicine Co., Ltd.
Aprea Therapeutics
Aprea Therapeutics
Akeso
Stanford University
Chinese PLA General Hospital
Seoul National University Hospital
pharmaand GmbH
pharmaand GmbH
H. Lee Moffitt Cancer Center and Research Institute
Ruhr University of Bochum
Ruhr University of Bochum
Kiadis Pharma
Southern Illinois University
AGO Study Group
Northwestern University
Peking Union Medical College Hospital
Chipscreen Biosciences, Ltd.
Masonic Cancer Center, University of Minnesota
University of Virginia
Dana-Farber Cancer Institute
Eli Lilly and Company
Novartis
Incyte Corporation
Vejle Hospital
ARCAGY/ GINECO GROUP
Chipscreen Biosciences, Ltd.
National Institutes of Health Clinical Center (CC)
Celgene
Assistance Publique - Hôpitaux de Paris
NYU Langone Health
Mayo Clinic
University College, London
Daiichi Sankyo
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Fred Hutchinson Cancer Center
University of Louisville
Fred Hutchinson Cancer Center
AstraZeneca
Novartis
Japan Clinical Oncology Group
University of Pittsburgh
Merrimack Pharmaceuticals
Sanofi
Sanofi
GlaxoSmithKline
National Institute of Cancerología
Cellectar Biosciences, Inc.
Jules Bordet Institute